Zanubrutinib is under clinical development by BeiGene and currently in Phase II for Lupus Nephritis. According to GlobalData, Phase II drugs for Lupus Nephritis have a 50% phase transition success ...

A 14-year-old patient presented to the ED with a 12-month history of joint pains and a 2-month history of headaches and ...

Belimumab is under clinical development by GSK and currently in Phase III for Rheumatoid Arthritis. According to GlobalData, Phase III drugs for Rheumatoid Arthritis have a 63% phase transition ...

Immune-Mediated Nephritis with Renal Dysfunction ... versus-host disease (GVHD), acute GVHD, chronic GVHD, hepatic veno-occlusive disease after reduced intensity conditioning, and steroid-requiring ...

Important risk factors for cSCC include chronic ultraviolet exposure and ... Immune-Mediated Nephritis with Renal Dysfunction UNLOXCYT can cause immune-mediated nephritis. Immune-Mediated ...

I would have been bored, except the pain was so tiring that I could barely function. I spent the days shuffling around the ...

SLE patients (n = 3389) who had undergone hysterectomy were less likely to develop nephritis or positive anti-double-strand DNA antibodies than age-matched SLE patients who had not (odds ratio ...

Stanford University School of Medicine–led researchers have found that intensive blood pressure (BP) control produces ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio WASHINGTON — Patients with lupus ...

(HealthDay News) — Interstitial cystitis and bladder pain syndrome (IC/BPS) vary in clinical manifestation, according to a study published online in the International Journal of Urology.